Latest News & Features
Europe
Appeals court overturns lower court ruling in decision establishing key standards for patent interpretation | Global dispute between the two insulin pump makers intensifies amid separate US trade secret litigation. 2 May 2025
Americas
Latest report highlights increasing concerns over counterfeit pharmaceuticals, IP barriers, and market access challenges | Key countries to watch include India, China, the UAE, and Singapore | Report also outlines challenges in Mexico, Russia, Brazil, and Indonesia. 1 May 2025
Americas
Duo behind Comirnaty fails to convince Delaware judge to dismiss Alnylam patent claims on grounds of invalidity. 1 May 2025
Careers
The firm has rehired Kate Hillier as a partner in its Bay Area office, where she will advise public and private life sciences companies on strategic partnering, licensing and complex IP transactions. 1 May 2025
Europe
EWHC ruling discusses application of EPO case law regarding lack of plausibility and lack of technical contribution | Court had earlier overturned a first-instance decision allowing an injunction against Glenmark’s diabetes generic | AstraZeneca intends to appeal. 29 April 2025
Africa
Genomic innovations involve vast amounts of research, making patents, copyrights, and trade secrets vital, explains Olusola Tunmise-Ajani of Inventa International. 29 April 2025
Americas
Proposed patent legislation will save US innovation and counter the ‘existential threat’ that China poses to the West, hears Sarah Speight. 29 April 2025
Americas
US district judge reduces award payable to Insulet by EOFlow to $59.4m l Dispute concerns wearable insulin patch pumps l Injunction remains but with allowance for users to access device temporarily. 29 April 2025
Americas
Case looked at whether generic treatment infringes ‘fridge temperature limitation method’ | Ruling underscores importance of clear labelling in drug patent infringement suits. 24 April 2025
Europe
Following the Unified Patent Court’s recent Meril v Edwards decision, Agathe Michel-de Cazotte & Ben Chapman of Carpmaels & Ransford examine the court’s treatment of obviousness to date. 24 April 2025